You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

tegafur

Showing 1 - 11 of 11
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Gastric Cancer Trial (Envolimab, Fuquinitinib, Oxaliplatin)

Not yet recruiting
  • Gastric Cancer
  • (no location specified)
Jun 13, 2023

Esophageal Cancer, Radiation Therapy, Immunotherapy Trial in Taizhou (Toripalimab, Tegafur, IMRT)

Recruiting
  • Esophageal Cancer
  • +3 more
  • Taizhou, Zhejiang, China
  • +1 more
Apr 15, 2023

Immunotherapy, Gastrict Cancer Trial in Fuzhou (Tislelizumab, Apatinib Mesylate, oxaliplatin)

Recruiting
  • Immunotherapy
  • Gastrict Cancer
  • Fuzhou, China
    Fujian cancer hospital
Jan 17, 2023

Stage IA Pancreatic Adenocarcinoma, Stage IB Pancreatic Adenocarcinoma, Stage IIA Pancreatic Adenocarcinoma Trial in Shanghai

Recruiting
  • Stage IA Pancreatic Adenocarcinoma
  • +3 more
  • Shanghai, China
    Department of Pancreatic and Hepatobiliary Surgery, Fudan Univer
Jun 27, 2020

Biliary Tract Tumors Trial in Taipei (Tegafur, Leucovorin, Oxaliplatin)

Recruiting
  • Biliary Tract Neoplasms
  • Tegafur
  • +4 more
  • Taipei, Taiwan
    Taiwan Cooperative Oncology Group, National Health Research Inst
Sep 15, 2020

Stomach Cancer Trial in Hangzhou (nab paclitaxel, Tegafur, Oxaliplatin)

Recruiting
  • Stomach Cancer
  • nab paclitaxel
  • +3 more
  • Hangzhou, Zhejiang, China
    Zhejiang Cancer Hospital；Cancer hospital of the university of ch
Mar 18, 2020

Gallbladder Carcinoma Trial in Shanghai (Apatinib, Tegafur)

Unknown status
  • Gallbladder Carcinoma
  • Shanghai, Shanghai, China
    xiao qing xiao qing Jiang
Oct 9, 2018

Hepatocellular Carcinoma Trial in Beijing (iNKT cells, IL-2, Tegafur)

Unknown status
  • Hepatocellular Carcinoma
  • iNKT cells
  • +2 more
  • Beijing, Beijing, China
    Beijing Youan Hospital,Capital Medical University
Jan 17, 2018

Extrapancreatic Neuroendocrine Tumor Trial in Beijing (Tegafur, Temozolomide, Thalidomide)

Unknown status
  • Extrapancreatic Neuroendocrine Tumor
  • Tegafur
  • +2 more
  • Beijing, Beijing, China
    Cancer Institute and Hospital, Chinese Academy of Medical Scienc
Jun 28, 2017

Hepatocellular Carcinoma Trial in Beijing (HCC antigens-specific CD8+ T lymphocytes, IL-2, Tegafur)

Unknown status
  • Hepatocellular Carcinoma
  • HCC antigens-specific CD8+ T lymphocytes
  • +2 more
  • Beijing, Beijing, China
    Beijing Youan Hospital,Capital Medical University
Jan 17, 2018

Colorectal Cancer Trial (5-fluorouracil, leucovorin calcium, tegafur)

Completed
  • Colorectal Cancer
  • (no location specified)
Jan 8, 2010